Abvc Biopharma ABVC
NASDAQ ABVC
$1.01 -0.01 (-0.98%)
At close: Oct 2, 2026 · 4:00 PM EDT

Abvc Biopharma (ABVC) Gains from Investment Securities (2018 - 2019)

Updated

Abvc Biopharma (ABVC) posted Gains from Investment Securities of $66,205 for Q1 2019, up 71.7% from $38,567 a year earlier but down 97.1% from the prior quarter.

Analysis

Abvc Biopharma (ABVC) Gains from Investment Securities (2018 - 2019) Analysis & Trends

For the trailing twelve months through Mar 31, 2019, Gains from Investment Securities at Abvc Biopharma was $2.58 million; for FY2018, it came in at $2.55 million.

  • Quarterly Gains from Investment Securities has run from a low of $38,567 in Q1 2018 to a high of $2.26 million in Q4 2018 over five years.
  • According to Business Quant data, Gains from Investment Securities for the three prior quarters was $2.26 million (Q4 2018), $201,590 (Q3 2018) and $47,356 (Q2 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Abvc Biopharma 26.03 Mn 28.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 66,205.00
Dec 31, 2018 2.26 Mn
Sep 30, 2018 201,590.00
Jun 30, 2018 47,356.00
Mar 31, 2018 38,567.00
API Access

Abvc Biopharma Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=ABVC&period=max&api_key=YOUR_API_KEY